MOLECULIN BIOTECH INC (MBRX) Forecast, Price Target & Analyst Ratings

NASDAQ:MBRX • US60855D4088

Current stock price

2.32 USD
0 (0%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MOLECULIN BIOTECH INC (MBRX).

Forecast Snapshot

Consensus Price Target

Price Target
$21.42
+ 823.28% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$1.70
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.22%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$21.42
Upside
+ 823.28%
From current price of $2.32 to mean target of $21.42, Based on 9 analyst forecasts
Low
$10.10
Median
$22.44
High
$32.55

Price Target Revisions

1 Month
-13.70%
3 Months
-58.82%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for MBRX. The average price target is 21.42 USD. This implies a price increase of 823.28% is expected in the next year compared to the current price of 2.32.
The average price target has been revised downward by 58.82% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

MBRX Current Analyst RatingMBRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

MBRX Historical Analyst RatingsMBRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.22%
MBRX was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MBRX.
In the previous month the buy percentage consensus was at a similar level.
MBRX was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-24HC Wainwright & Co.Reiterate Buy -> Buy
2025-12-11HC Wainwright & Co.Maintains Buy -> Buy
2025-09-10HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-27HC Wainwright & Co.Reiterate Buy -> Buy
2025-06-18HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-25Maxim GroupUpgrade Hold -> Buy
2025-03-25HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-24HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-03HC Wainwright & Co.Maintains Buy -> Buy
2024-11-12Maxim GroupMaintains Buy -> Buy
2024-04-12Roth MKMMaintains Buy -> Buy
2024-03-26Maxim GroupMaintains Buy -> Buy
2023-12-14HC Wainwright & Co.Initiate Buy
2023-04-18Roth MKMMaintains Buy
2023-03-24OppenheimerReiterate Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$1.70
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
90.16%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-0.05%
EPS (3 Months)
21.27%

Next Earnings Summary

MBRX is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -1.7 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
MBRX revenue by date.MBRX revenue by date.
N/AN/AN/AN/AN/AN/A
130.62%		N/A
33.06%		N/A
19.75%		N/A
42.27%
EBITDA
YoY % growth
MBRX ebitda by date.MBRX ebitda by date.
-454K-3.877M
-753.96%		-8.635M
-122.72%		-14.957M
-73.21%		-17.325M
-15.83%		-19.542M
-12.80%		-22.804M
-16.69%		-30.51M
-33.79%		-29.504M
3.30%		-26.515M
10.13%		N/A
2.67%		N/A
-9.09%		N/A
-17.39%		N/A
68.52%		N/A
465.69%		N/A
111.80%		N/A
83.16%		N/AN/A
EBIT
YoY % growth
MBRX ebit by date.MBRX ebit by date.
-465.3K-3.883M
-734.56%		-8.653M
-122.83%		-15.025M
-73.64%		-17.524M
-16.63%		-19.742M
-12.66%		-22.968M
-16.34%		-30.64M
-33.40%		-29.631M
3.29%		-26.641M
10.09%		N/A
6.61%		N/A
-14.18%		N/A
-3.53%		N/A
-5.11%		N/A
149.54%		N/A
414.32%		N/A
56.76%		N/A
25.34%		N/A
37.22%
Operating Margin
MBRX operating margin by date.MBRX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
MBRX eps by date.MBRX eps by date.
N/AN/AN/A
-46.88%		-1,035.00
4.05%		-765.00
26.09%		-660.00
13.73%		-221.25
66.48%		-378.75
-71.19%		-376.75
0.53%		-173.58
53.93%		-33.46
80.72%		N/A
79.71%		N/A
45.39%		N/A
-16.09%		N/A
193.60%		N/A
167.34%		N/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-1.70
90.16%		-1.49
87.84%		-1.11
93.46%		-1.05
-108.06%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-8.364M
-41.47%		-8.976M
-58.56%		-9.588M
-64.60%		-10.2M
-29.87%
EBIT
Q2Q % growth		-7.159M
-20.47%		-6.907M
-20.76%		-7.356M
-24.56%		-7.796M
-20.59%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MBRX Yearly Revenue VS EstimatesMBRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2029 2030 2031 2032 2033 100M 200M 300M
MBRX Yearly EPS VS EstimatesMBRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -200 -400 -600 -800 -1K

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
23.23%
EPS Next 5 Year
18.35%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-6.25%
EBIT Next 5 Year
27.59%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

MOLECULIN BIOTECH INC / MBRX Forecast FAQ

Can you provide the average price target for MOLECULIN BIOTECH INC stock?

9 analysts have analysed MBRX and the average price target is 21.42 USD. This implies a price increase of 823.28% is expected in the next year compared to the current price of 2.32.

What is the next earnings date for MBRX stock?

MOLECULIN BIOTECH INC (MBRX) will report earnings on 2026-05-11.

What are the consensus estimates for MOLECULIN BIOTECH INC (MBRX) next earnings?

The consensus EPS estimate for the next earnings of MOLECULIN BIOTECH INC (MBRX) is -1.7 USD and the consensus revenue estimate is 0 USD.

How many analysts have analysed MOLECULIN BIOTECH INC (MBRX)?

The number of analysts covering MOLECULIN BIOTECH INC (MBRX) is 9.